AAAAAA
Results: 51-57/57
Authors:
Cresta, P
Musset, L
Cacoub, P
Frangeul, L
Vitour, D
Poynard, T
Opolon, P
Nguyen, DT
Golliot, F
Piette, JC
Huraux, JM
Lunel, F
Citation: P. Cresta et al., Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus, GUT, 45(1), 1999, pp. 122
Authors:
Sobesky, R
Mathurin, P
Charlotte, F
Moussalli, J
Olivi, M
Vidaud, M
Ratziu, V
Opolon, P
Poynard, T
Citation: R. Sobesky et al., Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view, GASTROENTY, 116(2), 1999, pp. 378-386
Authors:
Cacoub, P
Poynard, T
Ghillani, P
Charlotte, F
Olivi, M
Piette, JC
Opolon, P
Citation: P. Cacoub et al., Extrahepatic manifestations of chronic hepatitis C, ARTH RHEUM, 42(10), 1999, pp. 2204-2212
Authors:
Mathurin, P
Taieb, J
Poynard, T
Citation: P. Mathurin et al., Corticosteroid therapy for severe alcoholic hepatitis: end of the controversy?, GASTRO CL B, 22(12), 1998, pp. 991-995
Authors:
Poynard, T
Piton, A
Bismuth, FI
Pelissier, E
Sansonetti, N
Opolon, P
Citation: T. Poynard et al., Diurnal variation of serum alanine transaminase activity in chronic liver disease - Reply, HEPATOLOGY, 28(6), 1998, pp. 1725-1725
Authors:
Poynard, T
Moussalli, J
Ratziu, V
Thevenot, T
Regimbeau, C
Opolon, P
Citation: T. Poynard et al., Is antiviral treatment (IFN alpha and/or Ribavirin) justified in cirrhosisrelated to hepatitis C virus? Pro, ACT GASTR B, 61(4), 1998, pp. 431-434
Authors:
Poynard, T
Moussali, J
Thevenot, T
Ratziu, V
Opolon, P
Citation: T. Poynard et al., Treatment of chronic hepatitis C with interferon: 1998 update, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 371-378